Detalhe da pesquisa
1.
Inefficient CAR-proximal signaling blunts antigen sensitivity.
Nat Immunol
; 21(8): 848-856, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32632291
2.
BATF3 programs CD8+ T cell memory.
Nat Immunol
; 21(11): 1397-1407, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32989328
3.
CAR T-cell therapy in multiple myeloma: mission accomplished?
Blood
; 143(4): 305-310, 2024 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38033289
4.
Engineering of potent CAR NK cells using non-viral Sleeping Beauty transposition from minimalistic DNA vectors.
Mol Ther
; 2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38751112
5.
Cytotoxicity of CD19-CAR-NK92 cells is primarily mediated via perforin/granzyme pathway.
Cancer Immunol Immunother
; 72(8): 2573-2583, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37052701
6.
Siglec-6 is a novel target for CAR T-cell therapy in acute myeloid leukemia.
Blood
; 138(19): 1830-1842, 2021 11 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34289026
7.
All-trans retinoic acid works synergistically with the γ-secretase inhibitor crenigacestat to augment BCMA on multiple myeloma and the efficacy of BCMA-CAR T cells.
Haematologica
; 108(2): 568-580, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36722406
8.
What is the future of immunotherapy in multiple myeloma?
Blood
; 136(22): 2491-2497, 2020 11 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-32735639
9.
Composite CD79A/CD40 co-stimulatory endodomain enhances CD19CAR-T cell proliferation and survival.
Mol Ther
; 29(9): 2677-2690, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33940156
10.
CARAMBA: a first-in-human clinical trial with SLAMF7 CAR-T cells prepared by virus-free Sleeping Beauty gene transfer to treat multiple myeloma.
Gene Ther
; 28(9): 560-571, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33846552
11.
γ-Secretase inhibition increases efficacy of BCMA-specific chimeric antigen receptor T cells in multiple myeloma.
Blood
; 134(19): 1585-1597, 2019 11 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31558469
12.
Elotuzumab for the treatment of extramedullary myeloma: a retrospective analysis of clinical efficacy and SLAMF7 expression patterns.
Ann Hematol
; 100(6): 1537-1546, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33575947
13.
New targets and technologies for CAR-T cells.
Curr Opin Oncol
; 32(5): 510-517, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32657796
14.
Overcoming key challenges in cancer immunotherapy with engineered T cells.
Curr Opin Oncol
; 32(5): 398-407, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32796230
15.
Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE).
Haematologica
; 105(2): 297-316, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31753925
16.
Chimeric Antigen Receptor Library Screening Using a Novel NF-κB/NFAT Reporter Cell Platform.
Mol Ther
; 27(2): 287-299, 2019 02 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30573301
17.
Chemically Programmable and Switchable CAR-T Therapy.
Angew Chem Int Ed Engl
; 59(29): 12178-12185, 2020 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-32329959
18.
Going non-viral: the Sleeping Beauty transposon system breaks on through to the clinical side.
Crit Rev Biochem Mol Biol
; 52(4): 355-380, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28402189
19.
Clinical Utilization of Chimeric Antigen Receptor T Cells in B Cell Acute Lymphoblastic Leukemia: An Expert Opinion from the European Society for Blood and Marrow Transplantation and the American Society for Blood and Marrow Transplantation.
Biol Blood Marrow Transplant
; 25(3): e76-e85, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30576834
20.
Highjacking myeloma's niche with beefed-up CAR-Ts.
Blood
; 139(26): 3671-3672, 2022 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35771562